In contrast, it exhibits prominent neoplastic overexpression in a subset of estrogen receptor-positive (ER+) primary tumors of the breast (16), going hand in hand with increased lymph node metastasis and reduced survival of patients (17–19). Here, ESR1 is linked to breast neoplasm.